Hjem › Endometriekreft › California › Baldwin Park
Kliniske studier for Endometriekreft i Baldwin Park, CA
17 studier for Endometriekreft søker deltakere på steder i og rundt Baldwin Park (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RekruttererFase 1/2
- Research Site, Duarte · 4 mi unna
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RekruttererFase 2
- City of Hope - Duarte Cancer Center, Duarte · 4 mi unna
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 2
- City of Hope, Duarte · 4 mi unna
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
RekruttererFase 1
- Research Site, Duarte · 4 mi unna
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
RekruttererFase 1/2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi unna
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekruttererFase 1
- City of Hope, Duarte · 4 mi unna
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruttererFase 1
- City of Hope Cancer Center, Duarte · 4 mi unna
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RekruttererFase 1/2
- City of Hope, Duarte · 4 mi unna
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekruttererFase 1
- City of Hope, Duarte · 4 mi unna
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
RekruttererFase 3
- Research Site, Duarte · 4 mi unna
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
RekruttererFase 1
- City of Hope, Duarte · 4 mi unna
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
RekruttererFase 2
- City of Hope National Medical Center, Duarte · 4 mi unna
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
Rekrutterer
- City of Hope Medical Center, Duarte · 4 mi unna
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
RekruttererFase 1
- The City of Hope National Medical Center, Duarte · 4 mi unna
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
RekruttererObservasjonsstudie
- Beckman Research Institute at City of Hope, Monrovia · 5 mi unna
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- City of Hope, Duarte · 4 mi unna
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Duarte · 4 mi unna
Endometriekreft-studier i andre byer
- Houston, TX68 studier
- New York City, NY52 studier
- Boston, MA50 studier
- Arlington, VA39 studier
- Nashville, TN38 studier
- Los Angeles, CA34 studier
- St. Louis, MO29 studier
- Philadelphia, PA28 studier
- San Antonio, TX27 studier
- Columbus, OH25 studier
- Oklahoma City, OK25 studier
- Chicago, IL25 studier
Andre studier i Baldwin Park
- Brystkreft44 studier
- Akut myelogen leukemi40 studier
- Kolorektal kreft37 studier
- Ikke-småcellet lungekreft36 studier
- Kreft (alle typer)34 studier
- Prostatakreft30 studier
- Metastatisk kreft30 studier
- Myelodysplastiske syndromer26 studier
- Eggstokkreft25 studier
- Lungekreft24 studier
- Multipelt myelom23 studier
- Mavekreft22 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.